Literature DB >> 8586729

Comparison of commercial diagnostic tests for identification of serogroup antigens of Neisseria meningitidis.

A van der Ende1, I G Schuurman, C T Hopman, C A Fijen, J Dankert.   

Abstract

In the study that is described the sensitivities and specificities of three commercial tests and the standard Reference Laboratory test, used since 1961, to identify Neisseria meningitidis serogroups were compared. The tests marketed by Difco, Murex/Wellcome, and Sanofi/Pasteur showed overall sensitivities of 92, 95, and 100%, respectively, and specificities of 67, 88, and 82%, respectively. When limited to the common serogroups A, B, and C, the three tests yielded sensitivities of 93, 97, and 100%, respectively, and specificities of 98, 100, and 98%, respectively. However, determination of the uncommon serogroups X, W-135, Y, Z, and 29E with these tests is either unreliable or not possible.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 8586729      PMCID： PMC228700          DOI： 10.1128/jcm.33.12.3326-3327.1995

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  7 in total

1.  Serological typing of meningococci by means of micro-precipitation.

Authors:  K W SLATERUS
Journal:  Antonie Van Leeuwenhoek       Date:  1961       Impact factor: 2.271

2.  THE MENINGOCOCCUS (NEISSERIA INTRACELLULARIS).

Authors:  S E Branham
Journal:  Bacteriol Rev       Date:  1940-06

Review 3.  Serotype antigens of Neisseria meningitidis and a proposed scheme for designation of serotypes.

Authors:  C E Frasch; W D Zollinger; J T Poolman
Journal:  Rev Infect Dis       Date:  1985 Jul-Aug

4.  An IgG monoclonal antibody to group B meningococci cross-reacts with developmentally regulated polysialic acid units of glycoproteins in neural and extraneural tissues.

Authors:  J Finne; D Bitter-Suermann; C Goridis; U Finne
Journal:  J Immunol       Date:  1987-06-15       Impact factor: 5.422

5.  Complement deficiencies in patients over ten years old with meningococcal disease due to uncommon serogroups.

Authors:  C A Fijen; E J Kuijper; A J Hannema; A G Sjöholm; J P van Putten
Journal:  Lancet       Date:  1989-09-09       Impact factor: 79.321

6.  Immunologic response of man to group B meningococcal polysaccharide vaccines.

Authors:  F A Wyle; M S Artenstein; B L Brandt; E C Tramont; D L Kasper; P L Altieri; S L Berman; J P Lowenthal
Journal:  J Infect Dis       Date:  1972-11       Impact factor: 5.226

7.  Association of meningococcal serogroups with the course of disease in the Netherlands, 1959-83.

Authors:  L Spanjaard; P Bol; S de Marie; H C Zanen
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408
  7 in total
  9 in total

Review 1.  Update on meningococcal disease with emphasis on pathogenesis and clinical management.

Authors:  M van Deuren; P Brandtzaeg; J W van der Meer
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

2.  International circumpolar surveillance interlaboratory quality control program for serotyping Haemophilus influenzae and serogrouping Neisseria meningitidis, 2005 to 2009.

Authors:  Raymond S W Tsang; Karen Rudolph; Marguerite Lovgren; Sadjia Bekal; Brigitte Lefebvre; Lotte Lambertsen; Tammy Zulz; Michael Bruce
Journal:  J Clin Microbiol       Date:  2011-12-14       Impact factor: 5.948

3.  Phenotypic and genotypic approaches to characterization of isolates of Neisseria meningitidis from patients and their close family contacts.

Authors:  G Tzanakaki; R Urwin; M Musilek; P Kriz; J Kremastinou; A Pangalis; C C Blackwell; M C Maiden
Journal:  J Clin Microbiol       Date:  2001-04       Impact factor: 5.948

4.  Serological specificities of murine hybridoma monoclonal antibodies against Neisseria meningitidis serogroups B, C, Y, and W135 and evaluation of their usefulness as serogrouping reagents by indirect whole-cell enzyme-linked immunosorbent assay.

Authors:  Raymond S W Tsang; Wendell D Zollinger
Journal:  Clin Diagn Lab Immunol       Date:  2005-01

5.  Use of real-time PCR to resolve slide agglutination discrepancies in serogroup identification of Neisseria meningitidis.

Authors:  Elizabeth A Mothershed; Claudio T Sacchi; Anne M Whitney; Gwen A Barnett; Gloria W Ajello; Susanna Schmink; Leonard W Mayer; Maureen Phelan; Thomas H Taylor; Scott A Bernhardt; Nancy E Rosenstein; Tanja Popovic
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

6.  sodC-based real-time PCR for detection of Neisseria meningitidis.

Authors:  Jennifer Dolan Thomas; Cynthia P Hatcher; Dara A Satterfield; M Jordan Theodore; Michelle C Bach; Kristin B Linscott; Xin Zhao; Xin Wang; Raydel Mair; Susanna Schmink; Kathryn E Arnold; David S Stephens; Lee H Harrison; Rosemary A Hollick; Ana Lucia Andrade; Juliana Lamaro-Cardoso; Ana Paula S de Lemos; Jenna Gritzfeld; Stephen Gordon; Ahmet Soysal; Mustafa Bakir; Dolly Sharma; Shabnam Jain; Sarah W Satola; Nancy E Messonnier; Leonard W Mayer
Journal:  PLoS One       Date:  2011-05-05       Impact factor: 3.240

7.  Genomic Insights on Variation Underlying Capsule Expression in Meningococcal Carriage Isolates From University Students, United States, 2015-2016.

Authors:  Melissa J Whaley; Jeni T Vuong; Nadav Topaz; How-Yi Chang; Jennifer Dolan Thomas; Laurel T Jenkins; Fang Hu; Susanna Schmink; Evelene Steward-Clark; Marsenia Mathis; Lorraine D Rodriguez-Rivera; Adam C Retchless; Sandeep J Joseph; Alexander Chen; Anna M Acosta; Lucy McNamara; Heidi M Soeters; Sarah Mbaeyi; Henju Marjuki; Xin Wang
Journal:  Front Microbiol       Date:  2022-02-17       Impact factor: 5.640

8.  A novel phase variation mechanism in the meningococcus driven by a ligand-responsive repressor and differential spacing of distal promoter elements.

Authors:  Matteo M E Metruccio; Eva Pigozzi; Davide Roncarati; Francesco Berlanda Scorza; Nathalie Norais; Stuart A Hill; Vincenzo Scarlato; Isabel Delany
Journal:  PLoS Pathog       Date:  2009-12-24       Impact factor: 6.823

9.  Improved survival of children with sepsis and purpura: effects of age, gender, and era.

Authors:  Martine Maat; Corinne M P Buysse; Marieke Emonts; Lodewijk Spanjaard; Koen F M Joosten; Ronald de Groot; Jan A Hazelzet
Journal:  Crit Care       Date:  2007       Impact factor: 9.097
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.